UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000041063
Receipt No. R000046898
Scientific Title Promotion of vocal development by mother's voice for preterm infants
Date of disclosure of the study information 2020/07/20
Last modified on 2022/07/19 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Promotion of vocal development by mother's voice for preterm infants
Acronym Always with Mom
Scientific Title Promotion of vocal development by mother's voice for preterm infants
Scientific Title:Acronym Always with Mom
Region
Japan

Condition
Condition preterm baby
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate whether recorded mother's voice improves development of infants at corrected 18 months.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Cognitive and verbal development quotient at corrected 18 months
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 Exposure to recorded mother's voice
Interventions/Control_2 Standard care
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 weeks-old <=
Age-upper limit
52 weeks-old >
Gender Male and Female
Key inclusion criteria Preterm infants requiring NICU care longer than 2 weeks
Key exclusion criteria 1) Congenital malformation
2) Chromosomal disorders
3) Hearing impairment
Target sample size 160

Research contact person
Name of lead principal investigator
1st name Osuke
Middle name
Last name Iwata
Organization Nagoya City University
Division name pediatrics
Zip code 4678601
Address 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya city
TEL 052-853-8246
Email o.iwata@med.nagoya-cu.ac.jp

Public contact
Name of contact person
1st name Osuke
Middle name
Last name Iwata
Organization Nagoya City University
Division name Pediatrics
Zip code 4678601
Address 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya city
TEL 052-853-8246
Homepage URL
Email o.iwata@med.nagoya-cu.ac.jp

Sponsor
Institute Nagoya City University
Institute
Department

Funding Source
Organization The Ministry of Education, Culture, Sports, Science and Technology(MEXT)
Grant-in-Aid for Scientific Research (KAKENHI)
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Clinical research management center, Nagoya city university hospital
Address 1, Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya city
Tel 052-851-5511
Email clinical_research@med.nagoya-cu.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 07 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 06 Month 17 Day
Date of IRB
2020 Year 06 Month 17 Day
Anticipated trial start date
2020 Year 08 Month 01 Day
Last follow-up date
2030 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 07 Month 10 Day
Last modified on
2022 Year 07 Month 19 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046898